Cancer Research Technology
Log in Register
Menu

VCaP androgen-independent cell line

Invented at Northern Institute For Cancer Research, Newcastle University

Info

Catalogue Number 154161
Parental Line VCaP
Host Human
Disease Keywords Human prostate adenocarcinoma
Model Tumour line
Relevance VCaP cells are androgen-sensitive human prostate adenocarcinoma cells established in 1997 from a vertebral bone metastasis from a 59-year-old Caucasian male with hormone refractory prostate cancer. This cell line is commonly used for prostate cancer research.
The cell line is a clonal population of VCaP cells grown in steroid-depleted conditions for ~4 months. Cells adapted to growth conditions and are now routinely grown in media lacking testosterone
Production Details VCaP cells grown in steroid-depleted conditions for ~4 months
Conditional No
Research Area Cancer
Recommended Growing Conditions DMEM + 10% FBS

References

There are 0 reference entries for this reagent.

References: 0 entry

There is no reference for this reagent yet, feel free to use the button below to suggest one.

Add a reference

References: 0 entry

There is no reference for this reagent yet, feel free to use the button below to suggest one.

Add a reference

Inventor Information